Founder and M.D.
Founder, provider, and medical director at our medspa, Dr. Sherly Soleiman has dedicated her entire sub-specialty to the art and safety of minimally invasive procedures using and teaching the latest and most advanced techniques. She is one of the most requested local faculties for Allergan (the company that makes Botox, Juvederm, Voluma, and Kybella), teaching other doctors and nurses how to inject their products safely and accurately.
Dr. Sherly Soleiman is very passionate about the art of injectables. It all started about 9 years ago when a filler procedure under her eyes by a reputable injector resulted in an unfavorable outcome. Since that event, Dr. Soleiman took it upon herself to learn all there is to know about the dynamics, safety, and different techniques of injections.
Dr. Soleiman understands the artistic side of providing cosmetic injections to her patients. In her vast array of studies, she has taken sculpting classes, studied painters, make-up artists, and photoshop specialist. All of these things have allowed her to gain extended knowledge of facial features, differentiators of male and female facial contours, as well as how lights and shadows can affect the signs of aging. With her extensive studies, she was able to share her knowledge with other providers and improve the artistic approach that is offered by everyone in the medspa. As a result, a more youthful appearance can be achieved.
Over the many years of dedication to the non-invasive cosmetic world, Dr. Soleiman has advanced to faculty level, being on the Advisory Board and becoming a clinical researcher in multiple injectables studies for Allergan (the company that makes Botox, Voluma, Juvederm, and Kybella).
Visiting a med spa for the first time involves more than booking an appointment. California law requires physician oversight for all medical aesthetic procedures, and patient safety depends on credentialed providers, transparent protocols, and informed preparation. At...
Think you know everything about Botox? Misinformation is everywhere—fueling fear, confusion, and missed opportunities for safe, natural-looking rejuvenation. Let’s cut through the noise with real science, expert insight, and the clinical experience of Dr. Sherly...
Facial wrinkles are not all the same—understanding the difference between dynamic and static wrinkles is critical for selecting the most effective, evidence-based non-surgical treatments. Scientific advances now allow for precise targeting of each wrinkle type,...
Non-surgical facial treatments like HydraFacial, chemical peels, and IPL Photofacial address a wide range of skin concerns, from acne and pigmentation to texture and signs of aging. Each procedure uses a distinct mechanism—hydradermabrasion, acid-induced exfoliation,...
Emsculpt NEO combines high-intensity focused electromagnetic (HIFEM) energy with synchronized radiofrequency (RF) to target both fat reduction and muscle hypertrophy in a single, noninvasive procedure. Clinical trials and systematic reviews demonstrate average...
Morpheus8 is a minimally invasive fractional radiofrequency (RF) microneedling device developed by InMode Ltd. It combines microneedles with RF energy to deliver controlled heat to the dermal and subdermal layers, stimulating collagen and elastin production while...
Laser Tattoo Removal: Scientific Overview Laser tattoo removal relies on selective photothermolysis, using targeted wavelengths to fragment ink particles for immune clearance. Q-switched and picosecond lasers are the most studied and FDA-cleared devices for this...
The Lumenis Stellar M22 is a multi-modality laser platform integrating Intense Pulsed Light (IPL), ResurFX (1565 nm non-ablative fractional laser), and Nd:YAG (long-pulsed and Q-switched 1064 nm) technologies. This system addresses over 30 indications, including skin...
The Cutera Excel V laser system combines 532 nm KTP and 1064 nm Nd:YAG wavelengths to address a wide range of vascular and pigmented skin concerns, including facial veins, rosacea, melasma, and lentigines, with clinical evidence supporting its safety and efficacy...
IV therapy and vitamin injections deliver nutrients directly into the bloodstream, bypassing the digestive system for rapid absorption. These treatments are used for specific medical indications such as nutrient deficiencies, malabsorption, and recovery from illness...
Acquired ptosis, or drooping of the upper eyelid, affects millions of adults and can impair both vision and appearance. Oxymetazoline 0.1% ophthalmic solution (Upneeq®) is the first FDA-approved, non-surgical therapy for acquired blepharoptosis in adults, offering...
Bimatoprost ophthalmic solution 0.03% (Latisse®) is the only FDA-approved prescription treatment for eyelash hypotrichosis, clinically proven to enhance eyelash length, thickness, and darkness through stimulation of the hair growth cycle. Since its approval in 2008...
Polidocanol, marketed as Asclera® in the United States, is an FDA-approved sclerosing agent used for the nonsurgical treatment of spider veins and reticular veins. Its efficacy and safety are supported by extensive clinical research, positioning it as a leading option...
GLP-1 and GIP agonist injectables, including semaglutide (Ozempic®, Wegovy®) and tirzepatide (Mounjaro®, Zepbound™), have transformed evidence-based medical weight loss, achieving up to 20% body weight reduction in clinical trials. Rapid weight loss can lead to...
Platelet-rich plasma (PRP), platelet-rich fibrin (PRF), and exosomes represent the forefront of regenerative injectables, offering cell-based and cell-free options for tissue repair, wound healing, and aesthetic rejuvenation. These therapies leverage autologous or...
